Carl Zeiss Meditec AG

XETRA AFX.DE

Carl Zeiss Meditec AG Return on Equity (ROE) for the year ending September 30, 2024: 8.75%

Carl Zeiss Meditec AG Return on Equity (ROE) is 8.75% for the year ending September 30, 2024, a -34.90% change year over year. Return on equity measures profit against shareholder equity; higher ROE indicates superior profitability and value creation.

Carl Zeiss Meditec AG Return on Equity (ROE) for the year ending September 30, 2023 was 13.45%, a -7.80% change year over year.
Carl Zeiss Meditec AG Return on Equity (ROE) for the year ending September 30, 2022 was 14.59%, a 2.43% change year over year.
Carl Zeiss Meditec AG Return on Equity (ROE) for the year ending September 30, 2021 was 14.24%, a 66.58% change year over year.
Carl Zeiss Meditec AG Return on Equity (ROE) for the year ending September 30, 2020 was 8.55%, a -25.17% change year over year.

Key data

Date	Return on Equity (ROE)	Return on Capital Employed (ROCE)	Interest Coverage Ratio	Debt to Equity Ratio

XETRA: AFX.DE

Carl Zeiss Meditec AG

CEO	Dr. Markus Weber
IPO Date	March 22, 2000
Location	Germany
Headquarters	Goschwitzer Strasse 51-52
Employees	4,823
Sector	Consumer Discretionary
Industries Eyewear 3D Printing Biotechnology Dental Care Glass Medical Instruments

Description

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, the United States, Asia, and internationally. It operates in two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers products and solutions for the diagnosis and treatment of eye diseases; and systems and consumables for cataract, retinal, and refractive surgeries. It serves practicing ophthalmologists and optometrists, as well as physicians and surgeons in hospitals and outpatient surgery centers. The Microsurgery segment offers visualization solutions for invasive surgical treatments; and solutions in the area of ear, nose and throat, plastic and reconstructive, dental and spinal surgeries. It serves physicians in various fields and hospitals. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG.

Key trends

Past 5 years